Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | CASP1 | P29466 | 1/20 | 0.34 |
| ▸ | CASP7 | P55210 | 1/20 | 0.34 |
| ▸ | HBB | P68871 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 2/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.34 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.33 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.33 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.33 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2459864 | 0.86 | ESR1 (0.38) | ALDH1A1HSD17B10CYP3A4TDP1ALOX15 | |
| SCHEMBL291173 | 0.86 | GSTP1 (0.42) | ALDH1A1HSD17B10ESR1ESR2HSD17B1 | |
| SCHEMBL2152944 | 0.85 | TDP1 (0.44) | ALDH1A1HSD17B10CYP3A4TDP1CYP1A2 | |
| SCHEMBL79020 | 0.81 | ALDH1A1 (0.35) | ALDH1A1HSD17B10TDP1MEN1KMT2A | |
| SCHEMBL29093556 | 0.78 | ESR1 (0.46) | ALDH1A1HSD17B10ALOX15ESR1ESR2 | |
| SCHEMBL3149589 | 0.78 | ALDH1A1 (0.38) | ALDH1A1HSD17B10CYP3A4TDP1ESR1 | |
| SCHEMBL4718441 | 0.76 | CYP3A4 (0.33) | ALDH1A1HSD17B10CYP3A4TDP1ALOX15 | |
| SCHEMBL28786162 | 0.76 | CYP2A6 (0.45) | ALDH1A1CYP1A2KDM4EMEN1TP53 | |
| SCHEMBL10594294 | 0.76 | ESR2 (0.52) | ALDH1A1CYP3A4ESR1ESR2HSD17B1 | |
| SCHEMBL27802197 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 619 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4383988-A1 | ORGANIC LIGHT EMITTING DIODE, DEVICE COMPRISING THE SAME AND COMPOUND | Novaled GmbH (DE) | 2024-06-12 | — | — | EP | claimed |
| CN-111051303-B | Nitrogen-containing cyclic compound and color conversion film comprising same | 株式会社LG化学 | 2023-06-02 | — | — | CN | claimed |
| CN-115710278-A | Fluoranthene oxazepine organic compound and preparation method and application thereof | 烟台九目化学股份有限公司 | 2023-02-24 | — | — | CN | claimed |
| CN-115677603-A | Organic electroluminescent compound and preparation method and application thereof | 阜阳欣奕华材料科技有限公司 | 2023-02-03 | — | — | CN | claimed |
| CN-114805092-A | Compound and organic electroluminescent device | 南京高光半导体材料有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-109411631-B | Terpyridine derivative and application thereof in organic luminescent material | 北京鼎材科技有限公司 | 2022-03-15 | — | — | CN | claimed |
| WO-2021136055-A1 | NITROGEN-CONTAINING ORGANIC COMPOUND, USE THEREOF, AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | 陕西莱特光电材料股份有限公司 | 2021-07-08 | — | — | WO | claimed |
| CN-111116584-B | Nitrogen-containing organic compound, application thereof and organic electroluminescent device using nitrogen-containing organic compound | 陕西莱特光电材料股份有限公司 | 2021-01-22 | — | — | CN | claimed |
| US-10686137-B2 | Aromatic amine derivative, and organic electroluminescent element comprising the same | IDEMITSU KOSAN CO., LTD. (JP) | 2020-06-16 | — | — | US | claimed |
| CN-111116584-A | Nitrogen-containing organic compound, application thereof and organic electroluminescent device using nitrogen-containing organic compound | 陕西莱特光电材料股份有限公司 | 2020-05-08 | — | — | CN | claimed |
| EP-0681019-A2 | Phenylanthracene derivative and organic EL element | TDK Corporation (JP) | 1995-11-08 | — | — | EP | claimed |
| EP-0052510-B2 | Microencapsulation of water soluble polypeptides | SYNTEX INC (US) | 1994-10-19 | — | — | EP | claimed |
| EP-0293632-B1 | DELIVERY SYSTEMS FOR THE CONTROLLED ADMINISTRATION OF LHRH ANALOGS | SYNTEX (U.S.A.) INC. (US) | 1992-10-07 | — | — | EP | claimed |
| EP-0166682-B1 | PROCESS FOR OBTAINING POSITIVE IMAGES | CIBA-GEIGY AG (CH) | 1992-01-08 | — | — | EP | claimed |
| US-4959217-A | HYDROGEL, RATE-LIMITING MEMBRANE | SYNTEX (U.S.A.) INC. (US) | 1990-09-25 | — | — | US | claimed |
| EP-0293632-A1 | Delivery systems for the controlled administration of LHRH analogs | SYNTEX (U.S.A.) INC. (US) | 1988-12-07 | — | — | EP | claimed |
| US-4675189-A | USING BIODEGRADABLE POLYMER; SUSTAINED RELEASE | SYNTEX (U.S.A.) INC. (US) | 1987-06-23 | — | — | US | claimed |
| EP-0052510-B1 | MICROENCAPSULATION OF WATER SOLUBLE POLYPEPTIDES | SYNTEX (U.S.A.) INC. (US) | 1986-08-27 | — | — | EP | claimed |
| EP-0166682-A2 | Process for obtaining positive images | CIBA-GEIGY AG (CH) | 1986-01-02 | — | — | EP | claimed |
| EP-0052510-A2 | Microencapsulation of water soluble polypeptides | SYNTEX (U.S.A.) INC. (US) | 1982-05-26 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10686137-B2 | Aromatic amine derivative, and organic electroluminescent element comprising the same | AR, H1-4, AFF4 | ALDH1A1 470/4885HSD17B10 3244/4885CYP3A4 416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.